The Harvard Annual Bioethics conference is open to the public, registration and a $50 fee are required to attend.
The Center for Bioethics is dedicated to keeping our educational programs affordable. If this fee would prevent you from attending, please contact the Center for Bioethics at 617-432-2570 and we will be happy to assist you.
April 11-13, 2018
Harvard Medical School Campus, Boston, MA
The 2018 Annual Bioethics Conference will explore the legacy of the 1968 report from the Harvard Medical School committee that proposed the concept of “brain death” as a new criterion for determining human death, making possible the procurement of “living” organs from bodies deemed to be “dead.” The conference will explore how this report facilitated the development of organ transplantation, assess current practices, and examine persistent controversies and challenges to the scientific and philosophical foundations of this concept. We will consider future strategies for facilitating the ethical procurement of organs for transplantation, and the impact of new technologies — such as gene editing and 3-D printing — that could radically alter the relevance of brain death as a concept necessary for organ procurement.
The Harvard Medical School Annual Bioethics Conference convenes leaders in the field to explore ethical questions and concerns in healthcare. Held each April, this two day, single track conference facilitates conversations among experts, and supports members of ethics committees, health care professionals, bioethicicists, administrators, attorneys and others who are interested in addressing ethical issues.
Conference Planning Committee:
Robert D. Truog, MD, Committee Chair
James L. Bernat, MD
Thomas I. Cochrane, MD
Christine Mitchell, RN, MS, MTS, FAAN
Lainie Ross, MD, PhD
Nicholas Sadovnikoff, MD
Robert Veatch, PhD
Sign up for updates and notifications about the conference.
2017: The Ethics of "Making Babies"
2016: Social Justice and Ethics Committees in Health Care
The Harvard Annual Bioethics Conference is hosted and organized by the Center for Bioethics at Harvard Medical School and co-sponsored by the Hastings Center and the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School with support from the Oswald DeN. Cammann Fund at Harvard University.